staff costs also expected to decline again next qtr, q2 has historically been our weakest qtr and it was very strong despite that. Whilst q2 is exciting, i think q3 could be something special. Plenty of newsflow too
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
staff costs also expected to decline again next qtr, q2 has...
Featured News
Add VHT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online